People

Services

Industries

Firm

About

Knowledge

Careers

News

Events

Contact

Connect

Privacy Policy

Disclaimer

Terms of Use

Accessibility

Payments

Legal

Calgary

Toronto

Edmonton

Ottawa

Vancouver

New York

Montréal

Vincent M. de Grandpré

IP Lawyer | Life Sciences & Tech

Partner

Melissa M. Dimilta

Intellectual Property Lawyer at Bennett Jones Toronto

Partner, Trademark Agent

As part of a deeply interconnected global sector, the life sciences industry in Canada is undergoing significant change alongside broad macroeconomic and geopolitical shifts.&nbsp;The Bennett Jones Life Sciences team looks at the top issues and developments affecting the industry in 2026.

2026 Life Sciences outlook

Legal and Market Trends to Watch This Year

Life Sciences Outlook 2026

Benjamin K. Reingold

Intellectual Property Litigation Lawyer at Bennett Jones Calgary

Emma Danaher

Commercial Litigation Lawyer at Bennett Jones Toronto

Associate 

Canada is advancing regulatory modernization through reforms aimed at improving efficiency, reducing duplication, and aligning with global standards. Key initiatives include streamlined biosimilar approval requirements, a proposed foreign reliance pathway for drug approvals, and amendments to medical device regulations. Together, these changes are expected to lower costs and accelerate market access for life sciences companies starting in 2026 and beyond.

Canada accelerates Regulatory Modernization

Biosimilar Approvals, Foreign Reliance Pathways and Global Harmonization

Canada Accelerates Regulatory Modernization

Lorelei Graham

IP Lawyer | Food & Agribusiness

This blog examines why Canada&rsquo;s Federal Court is the preferred venue for pharmaceutical patent litigation. It highlights its specialized expertise, efficient procedures and consistent, precedent-driven decisions.

Northern Advantage Canadas Federal Court as a Venue for Pharmaceutical Patent Litigation

Northern Advantage: Canada's Federal Court as a Venue for Pharmaceutical Patent Litigation

Dominique T. Hussey

Chief Executive Officer and Intellectual Property Litigator, Pharma/Biotech and Trademark Lawyer at Bennett Jones Toronto

Chief Executive Officer

Dominique Hussey and Melissa Dimilta co-author the Canada chapter in the first edition of World Trademark Review's <a rel="noopener noreferrer" rel="noopener noreferrer" href="https://www.worldtrademarkreview.com/review/the-trademark-litigation-review/2024" target="_blank">Trademark Litigation Review</a>.
This guide casts an expert eye on some of the most pressing issues facing those involved in litigation on both sides of the divide, blending analytic insight with on-the-ground expertise from key regions.

WTR Trademark Litigation Review 2024

WTR: Trademark Litigation Review 2024

Vasilis F. L. Pappas, FCIArb

International Arbitration Lawyer

Partner 

Melanie Teetaert

Commercial Litigation Lawyer at Bennett Jones Vancouver

Geoffrey P. Stenger

Energy, Infrastructure & Construction Lawyer | Bennett Jones Calgary

The Province of British Columbia has launched a six-week consultation on the implementation of the new Construction Prompt Payment Act. Industry stakeholders are invited to provide feedback on the Act's scope, potential exemptions and timing of implementation before the consultation closes on July 7, 2026. This update outlines the government's proposed approach and key issues under consideration.

BC Government Announces it is Soliciting Feedback on Prompt Payment Legislation

Andrew N. Disipio

Mining & Corporate Finance Lawyer | M&A, Equity & Debt Deals

Doug Fenton

Litigation Lawyer at Bennett Jones Toronto

Simon Grant

Financial Services & Regulatory Lawyer

The Supreme Court of Canada has granted leave to appeal a significant British Columbia case concerning mineral rights, Indigenous consultation and the application of UNDRIP in Canadian law. The decision will address whether courts can determine if provincial and federal legislation is consistent with UNDRIP and could have far-reaching implications for mineral claim acquisition, title certainty and natural resource project development across Canada. The ruling is expected to provide important guidance for mining companies, resource developers and Indigenous communities.

Supreme Court to Hear Landmark Case Involving Mineral Rights and Licensing Regimes

Kristopher R. Hanc

M&A and Capital Markets Lawyer at Bennett Jones Toronto

Brent W. Kraus

Corporate Governance Lawyer | Securities & Capital Markets

Co-Head of Mergers & Acquisitions Services

Christopher J. Doucet

Corporate & Mining Lawyer | M&A & Corporate Finance

On May 14, 2026, the Canadian Securities Administrators proposed wide-ranging amendments to Canada&rsquo;s issuer bid, take-over bid and early warning reporting regimes aimed at increasing flexibility, improving transparency around derivatives and reducing regulatory burden. Key changes include a potential selective repurchase exemption, enhanced disclosure for equity equivalent derivatives, and updated guidance on early warning reporting triggers and intentions. The proposals also codify certain exemptions and modernize bid mechanics in light of recent market practice and T+1 settlement.

CSA Proposes Amendments to the Issuer Bid Take Over Bid and Early Warning Regimes

CSA Proposes Amendments to the Issuer Bid, Take-Over Bid and Early Warning Regimes

Serge Dupont

Senior Advisor at Bennett Jones Ottawa

Senior Advisor

Policy and business leaders in 2026 are confronting disruptive global forces that pose daunting economic and financial risks while also transforming markets and creating avenues for growth over the next years.

Economic Outlook Mid Year 2026

A Changing World: New Risks, New Opportunities

2026 Mid-Year Economic Outlook

Alison G. FitzGerald

International Arbitration Lawyer at Bennett Jones Ottawa

Nasra Moumin

Associate

Global trade policy is rapidly reshaping the regulatory and commercial landscape for life sciences companies. This update explores how evolving US tariff measures, national security reviews, CUSMA renewal uncertainty and expanding export controls are affecting pharmaceutical and medical device manufacturers operating across borders. The authors also examine Canada&rsquo;s response and the growing compliance, supply chain and market access challenges facing the sector in 2026 and beyond.

The Impact of Global Trade on the Life Sciences Sector

Title Alphabetical

Title

normal

Primer on Remedies in IP Infringement Cases

From the Same Authors